Urothelial carcinoma of donor origin in a kidney transplant patient

BACKGROUND: Malignancy after transplantation is an uncommon multifactorial occurrence. Immunosuppression to prevent graft rejection is described as a major risk factor in malignancy development in the post-transplant state. Donor-derived malignancy is a rare reported complication. Herein, we review...

Descripción completa

Detalles Bibliográficos
Autores principales: Michel Ortega, Rosa M., Wolff, Daynna J., Schandl, Cynthia A., Drabkin, Harry A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067888/
https://www.ncbi.nlm.nih.gov/pubmed/27777772
http://dx.doi.org/10.1186/s40425-016-0167-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067888/
https://www.ncbi.nlm.nih.gov/pubmed/27777772
http://dx.doi.org/10.1186/s40425-016-0167-4

Ejemplares similares